CD8A and neoplasm: Dynamic interplay with the host immune response shapes the growth and evolution of a tumour, described by the three phases of “immunoediting”: initial elimination of tumour cells by immune components such as cytotoxic CD8+ T cells, followed by an equilibrium stage when tumour growth is held static, and finally immune escape when the host immune response is supressed or becomes tolerant to tumour antigens [107].